Stem cell therapy trial at Sanford first of its kind in US for shoulder injuries
The first FDA-approved clinical trial of its kind in the United States using a person’s own fat-derived adult stem cells to treat shoulder injuries is available at Sanford Health.
The trial opened in December and explores if adipose stem cells, which are taken from a participant’s own abdominal fat, can safely repair small and partial thickness tears in the rotator cuff by activating the body’s natural healing processes when injected into the injury area. The cell therapy technique may accelerate healing or regenerate tissue.
According to clinicaltrials.gov, it’s the only trial the FDA has approved that uses adipose stems cells for this type of injury.
Stem cell therapy trial at Sanford first of its kind in US for shoulder injuries
-
18. 04. 2017
MSCs for HBV-Related Acute-on-Chronic Liver Failure
-
10. 04. 2017
Stem cells used to treat erectile dysfunction
-
03. 04. 2017
Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia
-
27. 03. 2017
Mesenchymal stem cells in a murine ovalbumin asthma model
-
20. 03. 2017
Mesenchymal stem cells for lung melanoma metastases therapy